Literature DB >> 17712634

Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.

Ana Cristina Hernando-Harder1, Rudolf von Bünau, Mahaluxmy Nadarajah, Manfred Vincenz Singer, Hermann Harder.   

Abstract

E. coli strain Nissle 1917 (EcN) is a probiotic clinically used with various indications. However, especially at the beginning of treatment, some patients report abdominal bloating. In a prospective, randomized, double-blind study in 30 healthy individuals we assessed the influences of EcN on intestinal gas dynamics and abdominal sensation. After one week without medication volunteers orally received 2.5-25 x 10(9) colony-forming units of EcN or placebo per day for 21 days. EcN was well tolerated and did not significantly affect abdominal symptoms, stool frequency or stool consistency. During gas challenge at different days no difference in the perception scores (range from 0 = no perception to 6 = pain) was observed between the two groups: the mean perception score was 1.2 (SD 0.2) in the EcN group and 1.4 (SD 0.2) in the placebo group. EcN had no relevant influence on intestinal gas dynamics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712634     DOI: 10.1007/s10620-007-9892-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  The pathogenesis of bloating and visible distension in irritable bowel syndrome.

Authors:  Fernando Azpiroz; Juan R Malagelada
Journal:  Gastroenterol Clin North Am       Date:  2005-06       Impact factor: 3.806

Review 2.  VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.

Authors:  Paolo Gionchetti; Karen M Lammers; Fernando Rizzello; Massimo Campieri
Journal:  Gastroenterol Clin North Am       Date:  2005-09       Impact factor: 3.806

Review 3.  Probiotics and intestinal inflammatory disorders in infants and children.

Authors:  J A Vanderhoof
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000       Impact factor: 2.839

4.  Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.

Authors:  Lesley A Houghton; Richard Lea; Anurag Agrawal; Anvrag Agrawal; Brian Reilly; Peter J Whorwell
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

5.  [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].

Authors:  H J Krammer; H Kämper; R von Bünau; E Zieseniss; C Stange; F Schlieger; I Clever; J Schulze
Journal:  Z Gastroenterol       Date:  2006-08       Impact factor: 2.000

6.  Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Authors:  W Kruis; E Schütz; P Fric; B Fixa; G Judmaier; M Stolte
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

Review 7.  [Probiotics in inflammatory bowel disease: controlled trials and perspectives].

Authors:  Philippe Seksik; Philippe Marteau
Journal:  Therapie       Date:  2004 Jan-Feb       Impact factor: 2.070

8.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  Properties of Escherichia coli strains of serotype O6.

Authors:  G Blum; R Marre; J Hacker
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

10.  A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.

Authors:  H J Kim; M Camilleri; S McKinzie; M B Lempke; D D Burton; G M Thomforde; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2003-04-01       Impact factor: 8.171

View more
  1 in total

Review 1.  Insights from 100 Years of Research with Probiotic E. Coli.

Authors:  Trudy M Wassenaar
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.